| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.094 | 0.7 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |